ID DUOX1_HUMAN Reviewed; 1551 AA. AC Q9NRD9; A6NH28; Q14C94; Q6ZMB3; Q6ZR09; Q9NZC1; DT 21-FEB-2006, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2000, sequence version 1. DT 27-MAR-2024, entry version 181. DE RecName: Full=Dual oxidase 1; DE EC=1.11.1.-; DE EC=1.6.3.1; DE AltName: Full=Large NOX 1; DE AltName: Full=Long NOX 1; DE AltName: Full=NADPH thyroid oxidase 1; DE AltName: Full=Thyroid oxidase 1; DE Flags: Precursor; GN Name=DUOX1; Synonyms=DUOX, LNOX1, THOX1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE RP SPECIFICITY, AND INDUCTION. RC TISSUE=Thyroid; RX PubMed=10806195; DOI=10.1074/jbc.m000916200; RA De Deken X., Wang D., Many M.-C., Costagliola S., Libert F., Vassart G., RA Dumont J.E., Miot F.; RT "Cloning of two human thyroid cDNAs encoding new members of the NADPH RT oxidase family."; RL J. Biol. Chem. 275:23227-23233(2000). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT PHE-1178, FUNCTION, RP CATALYTIC ACTIVITY, ACTIVITY REGULATION, DEVELOPMENTAL STAGE, AND TISSUE RP SPECIFICITY. RC TISSUE=Lung; RX PubMed=11514595; DOI=10.1083/jcb.200103132; RA Edens W.A., Sharling L., Cheng G., Shapira R., Kinkade J.M., Lee T., RA Edens H.A., Tang X., Sullards C., Flaherty D.B., Benian G.M., Lambeth J.D.; RT "Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a RT multidomain oxidase/peroxidase with homology to the phagocyte oxidase RT subunit gp91phox."; RL J. Cell Biol. 154:879-891(2001). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE RP [LARGE SCALE MRNA] OF 1030-1551 (ISOFORMS 1/2), AND VARIANT ARG-1026. RC TISSUE=Lung, and Trachea; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16572171; DOI=10.1038/nature04601; RA Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K., RA Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K., RA FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N., RA Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S., RA Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K., RA DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J., RA Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E., RA Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B., RA Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R., RA O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B., RA Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S., RA Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.; RT "Analysis of the DNA sequence and duplication history of human chromosome RT 15."; RL Nature 440:671-675(2006). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP GLYCOSYLATION. RX PubMed=11822874; DOI=10.1006/excr.2001.5444; RA De Deken X., Wang D., Dumont J.E., Miot F.; RT "Characterization of ThOX proteins as components of the thyroid H(2)O(2)- RT generating system."; RL Exp. Cell Res. 273:187-196(2002). RN [7] RP FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=12824283; DOI=10.1096/fj.02-1104fje; RA Geiszt M., Witta J., Baffi J., Lekstrom K., Leto T.L.; RT "Dual oxidases represent novel hydrogen peroxide sources supporting mucosal RT surface host defense."; RL FASEB J. 17:1502-1504(2003). RN [8] RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=15210697; DOI=10.1074/jbc.m404983200; RA Schwarzer C., Machen T.E., Illek B., Fischer H.; RT "NADPH oxidase-dependent acid production in airway epithelial cells."; RL J. Biol. Chem. 279:36454-36461(2004). RN [9] RP INDUCTION. RX PubMed=16111680; DOI=10.1016/j.febslet.2005.08.002; RA Harper R.W., Xu C., Eiserich J.P., Chen Y., Kao C.-Y., Thai P., Setiadi H., RA Wu R.; RT "Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and RT Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium."; RL FEBS Lett. 579:4911-4917(2005). RN [10] RP INTERACTION WITH TXNDC11; TPO AND CYBA. RX PubMed=15561711; DOI=10.1074/jbc.m407709200; RA Wang D., De Deken X., Milenkovic M., Song Y., Pirson I., Dumont J.E., RA Miot F.; RT "Identification of a novel partner of duox: EFP1, a thioredoxin-related RT protein."; RL J. Biol. Chem. 280:3096-3103(2005). RN [11] RP CATALYTIC ACTIVITY, AND ACTIVITY REGULATION. RX PubMed=15972824; DOI=10.1074/jbc.m500516200; RA Ameziane-El-Hassani R., Morand S., Boucher J.L., Frapart Y.-M., RA Apostolou D., Agnandji D., Gnidehou S., Ohayon R., Noel-Hudson M.-S., RA Francon J., Lalaoui K., Virion A., Dupuy C.; RT "Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity."; RL J. Biol. Chem. 280:30046-30054(2005). CC -!- FUNCTION: Generates hydrogen peroxide which is required for the CC activity of thyroid peroxidase/TPO and lactoperoxidase/LPO. Plays a CC role in thyroid hormones synthesis and lactoperoxidase-mediated CC antimicrobial defense at the surface of mucosa. May have its own CC peroxidase activity through its N-terminal peroxidase-like domain. CC {ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:12824283}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+) + NADH + O2 = H2O2 + NAD(+); Xref=Rhea:RHEA:11264, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.6.3.1; CC Evidence={ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:15972824}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+) + NADPH + O2 = H2O2 + NADP(+); Xref=Rhea:RHEA:11260, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.6.3.1; CC Evidence={ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:15972824}; CC -!- ACTIVITY REGULATION: The NADPH oxidase activity is calcium-dependent. CC Peroxidase activity is inhibited by aminobenzohydrazide. CC {ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:15972824}. CC -!- PATHWAY: Hormone biosynthesis; thyroid hormone biosynthesis. CC -!- SUBUNIT: Interacts with TXNDC11, TPO and CYBA. CC {ECO:0000269|PubMed:15561711}. CC -!- SUBCELLULAR LOCATION: Apical cell membrane CC {ECO:0000269|PubMed:10806195, ECO:0000269|PubMed:15210697}; Multi-pass CC membrane protein {ECO:0000269|PubMed:10806195, CC ECO:0000269|PubMed:15210697}. Note=Localizes to the apical membrane of CC epithelial cells. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9NRD9-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9NRD9-2; Sequence=VSP_017262, VSP_017263; CC -!- TISSUE SPECIFICITY: Expressed in thyrocytes and tracheal surface CC epithelial cells (at protein level). Expressed in thyroid, trachea, CC bronchium, and to a lower extent, in placenta, testis, prostate, CC pancreas and heart. {ECO:0000269|PubMed:10806195, CC ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:12824283, CC ECO:0000269|PubMed:15210697}. CC -!- DEVELOPMENTAL STAGE: Widely expressed in fetal tissues. CC {ECO:0000269|PubMed:11514595}. CC -!- INDUCTION: By forskolin (at protein level). By thyrotropin and the Th2- CC specific cytokines IL-4 and IL-13. {ECO:0000269|PubMed:10806195, CC ECO:0000269|PubMed:16111680}. CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11822874}. CC -!- SIMILARITY: In the N-terminal section; belongs to the peroxidase CC family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AK128591; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305}; CC Sequence=BAD18816.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF230495; AAF73921.1; -; mRNA. DR EMBL; AF213465; AAF71295.1; -; mRNA. DR EMBL; AK128591; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AK172859; BAD18816.1; ALT_INIT; mRNA. DR EMBL; AC051619; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC114628; AAI14629.1; -; mRNA. DR CCDS; CCDS32221.1; -. [Q9NRD9-1] DR RefSeq; NP_059130.2; NM_017434.4. [Q9NRD9-1] DR RefSeq; NP_787954.1; NM_175940.2. [Q9NRD9-1] DR RefSeq; XP_011519984.1; XM_011521682.1. [Q9NRD9-2] DR PDB; 7D3E; EM; 2.80 A; A/C=1-1551. DR PDB; 7D3F; EM; 2.30 A; A/C=1-1551. DR PDBsum; 7D3E; -. DR PDBsum; 7D3F; -. DR AlphaFoldDB; Q9NRD9; -. DR SMR; Q9NRD9; -. DR BioGRID; 119815; 12. DR ComplexPortal; CPX-8183; DUOX1-DUOXA1 dual oxidase complex. DR IntAct; Q9NRD9; 3. DR STRING; 9606.ENSP00000317997; -. DR PeroxiBase; 3339; HsDuOx01. DR TCDB; 5.B.1.1.6; the phagocyte (gp91(phox)) nadph oxidase family. DR GlyCosmos; Q9NRD9; 5 sites, No reported glycans. DR GlyGen; Q9NRD9; 6 sites, 1 O-linked glycan (1 site). DR iPTMnet; Q9NRD9; -. DR PhosphoSitePlus; Q9NRD9; -. DR BioMuta; DUOX1; -. DR DMDM; 74719102; -. DR EPD; Q9NRD9; -. DR jPOST; Q9NRD9; -. DR MassIVE; Q9NRD9; -. DR MaxQB; Q9NRD9; -. DR PaxDb; 9606-ENSP00000317997; -. DR PeptideAtlas; Q9NRD9; -. DR ProteomicsDB; 82341; -. [Q9NRD9-1] DR ProteomicsDB; 82342; -. [Q9NRD9-2] DR Antibodypedia; 11716; 149 antibodies from 28 providers. DR DNASU; 53905; -. DR Ensembl; ENST00000321429.8; ENSP00000317997.4; ENSG00000137857.18. [Q9NRD9-1] DR Ensembl; ENST00000389037.7; ENSP00000373689.3; ENSG00000137857.18. [Q9NRD9-1] DR Ensembl; ENST00000561166.1; ENSP00000454065.1; ENSG00000137857.18. [Q9NRD9-2] DR GeneID; 53905; -. DR KEGG; hsa:53905; -. DR MANE-Select; ENST00000389037.7; ENSP00000373689.3; NM_175940.3; NP_787954.1. DR UCSC; uc001zus.3; human. [Q9NRD9-1] DR AGR; HGNC:3062; -. DR CTD; 53905; -. DR DisGeNET; 53905; -. DR GeneCards; DUOX1; -. DR HGNC; HGNC:3062; DUOX1. DR HPA; ENSG00000137857; Tissue enhanced (esophagus, skin). DR MIM; 606758; gene. DR neXtProt; NX_Q9NRD9; -. DR OpenTargets; ENSG00000137857; -. DR PharmGKB; PA27516; -. DR VEuPathDB; HostDB:ENSG00000137857; -. DR eggNOG; KOG0039; Eukaryota. DR GeneTree; ENSGT00940000161792; -. DR HOGENOM; CLU_004482_1_0_1; -. DR InParanoid; Q9NRD9; -. DR OMA; VTSEIIM; -. DR OrthoDB; 367877at2759; -. DR PhylomeDB; Q9NRD9; -. DR TreeFam; TF105424; -. DR BRENDA; 1.6.3.1; 2681. DR PathwayCommons; Q9NRD9; -. DR Reactome; R-HSA-209968; Thyroxine biosynthesis. DR SABIO-RK; Q9NRD9; -. DR SignaLink; Q9NRD9; -. DR SIGNOR; Q9NRD9; -. DR UniPathway; UPA00194; -. DR BioGRID-ORCS; 53905; 10 hits in 1143 CRISPR screens. DR ChiTaRS; DUOX1; human. DR GeneWiki; Dual_oxidase_1; -. DR GenomeRNAi; 53905; -. DR Pharos; Q9NRD9; Tbio. DR PRO; PR:Q9NRD9; -. DR Proteomes; UP000005640; Chromosome 15. DR RNAct; Q9NRD9; Protein. DR Bgee; ENSG00000137857; Expressed in tongue squamous epithelium and 138 other cell types or tissues. DR ExpressionAtlas; Q9NRD9; baseline and differential. DR GO; GO:0016324; C:apical plasma membrane; NAS:UniProtKB. DR GO; GO:0031252; C:cell leading edge; IGI:UniProtKB. DR GO; GO:0009986; C:cell surface; IGI:UniProtKB. DR GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB. DR GO; GO:0043020; C:NADPH oxidase complex; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0020037; F:heme binding; IEA:InterPro. DR GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; TAS:Reactome. DR GO; GO:0106293; F:NADH oxidase H202-forming activity; IEA:RHEA. DR GO; GO:0050661; F:NADP binding; NAS:UniProtKB. DR GO; GO:0106294; F:NADPH oxidase H202-forming activity; IEA:RHEA. DR GO; GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW. DR GO; GO:0016175; F:superoxide-generating NAD(P)H oxidase activity; IBA:GO_Central. DR GO; GO:0042335; P:cuticle development; IMP:UniProtKB. DR GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB. DR GO; GO:0006952; P:defense response; IBA:GO_Central. DR GO; GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0050665; P:hydrogen peroxide biosynthetic process; IGI:UniProtKB. DR GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW. DR GO; GO:2000147; P:positive regulation of cell motility; IGI:UniProtKB. DR GO; GO:0090303; P:positive regulation of wound healing; IGI:UniProtKB. DR GO; GO:0051591; P:response to cAMP; IDA:UniProtKB. DR GO; GO:0006979; P:response to oxidative stress; IEA:InterPro. DR GO; GO:0042554; P:superoxide anion generation; IBA:GO_Central. DR GO; GO:0006590; P:thyroid hormone generation; TAS:Reactome. DR CDD; cd09820; dual_peroxidase_like; 1. DR CDD; cd00051; EFh; 2. DR CDD; cd06186; NOX_Duox_like_FAD_NADP; 1. DR Gene3D; 1.10.238.10; EF-hand; 1. DR Gene3D; 1.10.640.10; Haem peroxidase domain superfamily, animal type; 1. DR Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1. DR Gene3D; 2.40.30.10; Translation factors; 1. DR InterPro; IPR034821; DUOX_peroxidase. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR018247; EF_Hand_1_Ca_BS. DR InterPro; IPR002048; EF_hand_dom. DR InterPro; IPR013112; FAD-bd_8. DR InterPro; IPR017927; FAD-bd_FR_type. DR InterPro; IPR013130; Fe3_Rdtase_TM_dom. DR InterPro; IPR013121; Fe_red_NAD-bd_6. DR InterPro; IPR039261; FNR_nucleotide-bd. DR InterPro; IPR019791; Haem_peroxidase_animal. DR InterPro; IPR010255; Haem_peroxidase_sf. DR InterPro; IPR037120; Haem_peroxidase_sf_animal. DR InterPro; IPR017938; Riboflavin_synthase-like_b-brl. DR PANTHER; PTHR11972:SF75; DUAL OXIDASE 1; 1. DR PANTHER; PTHR11972; NADPH OXIDASE; 1. DR Pfam; PF03098; An_peroxidase; 1. DR Pfam; PF00036; EF-hand_1; 1. DR Pfam; PF13499; EF-hand_7; 1. DR Pfam; PF08022; FAD_binding_8; 1. DR Pfam; PF01794; Ferric_reduct; 1. DR Pfam; PF08030; NAD_binding_6; 1. DR PRINTS; PR00457; ANPEROXIDASE. DR SFLD; SFLDS00052; Ferric_Reductase_Domain; 1. DR SFLD; SFLDG01168; Ferric_reductase_subgroup_(FRE; 1. DR SFLD; SFLDG01169; NADPH_oxidase_subgroup_(NOX); 1. DR SMART; SM00054; EFh; 2. DR SUPFAM; SSF47473; EF-hand; 1. DR SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1. DR SUPFAM; SSF48113; Heme-dependent peroxidases; 1. DR SUPFAM; SSF63380; Riboflavin synthase domain-like; 1. DR PROSITE; PS00018; EF_HAND_1; 2. DR PROSITE; PS50222; EF_HAND_2; 3. DR PROSITE; PS51384; FAD_FR; 1. DR PROSITE; PS50292; PEROXIDASE_3; 1. DR Genevisible; Q9NRD9; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Calcium; Cell membrane; FAD; KW Flavoprotein; Glycoprotein; Hydrogen peroxide; Membrane; Metal-binding; KW NADP; Oxidoreductase; Peroxidase; Reference proteome; Repeat; Signal; KW Thyroid hormones biosynthesis; Transmembrane; Transmembrane helix. FT SIGNAL 1..21 FT /evidence="ECO:0000255" FT CHAIN 22..1551 FT /note="Dual oxidase 1" FT /id="PRO_0000223344" FT TOPO_DOM 22..596 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 597..617 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 618..1044 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1045..1065 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1066..1080 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1081..1101 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1102..1148 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1149..1171 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1172..1188 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1189..1209 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1210..1226 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1227..1247 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1248 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1249..1269 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1270..1551 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 815..850 FT /note="EF-hand 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 851..886 FT /note="EF-hand 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 895..930 FT /note="EF-hand 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 1087..1269 FT /note="Ferric oxidoreductase" FT DOMAIN 1270..1376 FT /note="FAD-binding FR-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00716" FT REGION 26..593 FT /note="Peroxidase-like; mediates peroxidase activity" FT REGION 150..172 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 956..1248 FT /note="Interaction with TXNDC11" FT /evidence="ECO:0000250" FT COMPBIAS 153..167 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 828 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 830 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 832 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 834 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 839 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 864 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 866 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 868 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 875 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT CARBOHYD 94 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 342 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 354 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 461 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 534 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 1..354 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_017262" FT VAR_SEQ 355..405 FT /note="SSVSRALRVCNSYWSREHPSLQSAEDVDALLLGMASQIAEREDHVLVEDVR FT -> MWMHCCWAWPPRSQSERTMCWLKMCGVSLRLSLQVVNSWPLGRGSAGLPEP (in FT isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_017263" FT VARIANT 962 FT /note="I -> T (in dbSNP:rs16939743)" FT /id="VAR_049104" FT VARIANT 1026 FT /note="C -> R (in dbSNP:rs16939752)" FT /evidence="ECO:0000269|PubMed:14702039" FT /id="VAR_025321" FT VARIANT 1178 FT /note="L -> F (in dbSNP:rs2458236)" FT /evidence="ECO:0000269|PubMed:11514595" FT /id="VAR_025322" FT CONFLICT 413 FT /note="K -> E (in Ref. 3; AK128591)" FT /evidence="ECO:0000305" FT CONFLICT 1388 FT /note="G -> R (in Ref. 3; BAD18816)" FT /evidence="ECO:0000305" FT STRAND 38..40 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 42..45 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 60..64 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 69..71 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 75..83 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 97..110 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 132..134 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 155..158 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 171..175 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 176..179 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 183..189 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 221..223 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 228..230 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 237..240 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 243..266 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 272..293 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 295..300 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 320..331 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 336..338 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 357..363 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 378..390 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 396..398 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 402..405 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 411..417 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 419..429 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 435..441 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 450..452 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 455..459 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 464..471 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 472..474 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 476..478 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 481..488 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 490..492 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 495..510 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 519..521 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 526..534 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 537..545 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 549..551 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 563..565 FT /evidence="ECO:0007829|PDB:7D3E" FT HELIX 592..618 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 645..648 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 652..654 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 657..663 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 665..672 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 677..682 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 690..693 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 701..705 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 707..709 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 712..715 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 719..734 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 741..744 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 747..752 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 757..775 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 792..798 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 804..811 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 818..827 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 832..835 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 837..849 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 852..863 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 868..871 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 873..883 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 894..901 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 917..923 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 1025..1027 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1028..1068 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 1071..1074 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 1076..1078 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1081..1099 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1100..1104 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1106..1113 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1116..1119 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1123..1125 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1126..1157 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1160..1166 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 1168..1170 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1182..1187 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1190..1208 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1211..1216 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1219..1225 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1228..1238 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 1239..1241 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1243..1245 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1249..1269 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1273..1275 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1277..1283 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 1284..1286 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1287..1293 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1305..1310 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1311..1313 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1319..1323 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1329..1337 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1341..1349 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1364..1367 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1376..1379 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1380..1388 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1389..1392 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1393..1408 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1416..1424 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1430..1442 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1448..1454 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1458..1460 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1463..1473 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1478..1481 FT /evidence="ECO:0007829|PDB:7D3F" FT TURN 1483..1485 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1488..1494 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1498..1508 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1509..1511 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1513..1521 FT /evidence="ECO:0007829|PDB:7D3F" FT HELIX 1523..1538 FT /evidence="ECO:0007829|PDB:7D3F" FT STRAND 1539..1548 FT /evidence="ECO:0007829|PDB:7D3F" SQ SEQUENCE 1551 AA; 177235 MW; 37CF124A579446B0 CRC64; MGFCLALAWT LLVGAWTPLG AQNPISWEVQ RFDGWYNNLM EHRWGSKGSR LQRLVPASYA DGVYQPLGEP HLPNPRDLSN TISRGPAGLA SLRNRTVLGV FFGYHVLSDL VSVETPGCPA EFLNIRIPPG DPMFDPDQRG DVVLPFQRSR WDPETGRSPS NPRDPANQVT GWLDGSAIYG SSHSWSDALR SFSRGQLASG PDPAFPRDSQ NPLLMWAAPD PATGQNGPRG LYAFGAERGN REPFLQALGL LWFRYHNLWA QRLARQHPDW EDEELFQHAR KRVIATYQNI AVYEWLPSFL QKTLPEYTGY RPFLDPSISS EFVAASEQFL STMVPPGVYM RNASCHFQGV INRNSSVSRA LRVCNSYWSR EHPSLQSAED VDALLLGMAS QIAEREDHVL VEDVRDFWPG PLKFSRTDHL ASCLQRGRDL GLPSYTKARA ALGLSPITRW QDINPALSRS NDTVLEATAA LYNQDLSWLE LLPGGLLESH RDPGPLFSTI VLEQFVRLRD GDRYWFENTR NGLFSKKEIE EIRNTTLQDV LVAVINIDPS ALQPNVFVWH KGDPCPQPRQ LSTEGLPACA PSVVRDYFEG SGFGFGVTIG TLCCFPLVSL LSAWIVARLR MRNFKRLQGQ DRQSIVSEKL VGGMEALEWQ GHKEPCRPVL VYLQPGQIRV VDGRLTVLRT IQLQPPQKVN FVLSSNRGRR TLLLKIPKEY DLVLLFNLEE ERQALVENLR GALKESGLSI QEWELREQEL MRAAVTREQR RHLLETFFRH LFSQVLDINQ ADAGTLPLDS SQKVREALTC ELSRAEFAES LGLKPQDMFV ESMFSLADKD GNGYLSFREF LDILVVFMKG SPEEKSRLMF RMYDFDGNGL ISKDEFIRML RSFIEISNNC LSKAQLAEVV ESMFRESGFQ DKEELTWEDF HFMLRDHNSE LRFTQLCVKG VEVPEVIKDL CRRASYISQD MICPSPRVSA RCSRSDIETE LTPQRLQCPM DTDPPQEIRR RFGKKVTSFQ PLLFTEAHRE KFQRSCLHQT VQQFKRFIEN YRRHIGCVAV FYAIAGGLFL ERAYYYAFAA HHTGITDTTR VGIILSRGTA ASISFMFSYI LLTMCRNLIT FLRETFLNRY VPFDAAVDFH RLIASTAIVL TVLHSVGHVV NVYLFSISPL SVLSCLFPGL FHDDGSELPQ KYYWWFFQTV PGLTGVVLLL ILAIMYVFAS HHFRRRSFRG FWLTHHLYIL LYVLLIIHGS FALIQLPRFH IFFLVPAIIY GGDKLVSLSR KKVEISVVKA ELLPSGVTHL RFQRPQGFEY KSGQWVRIAC LALGTTEYHP FTLTSAPHED TLSLHIRAAG PWTTRLREIY SAPTGDRCAR YPKLYLDGPF GEGHQEWHKF EVSVLVGGGI GVTPFASILK DLVFKSSVSC QVFCKKIYFI WVTRTQRQFE WLADIIREVE ENDHQDLVSV HIYITQLAEK FDLRTTMLYI CERHFQKVLN RSLFTGLRSI THFGRPPFEP FFNSLQEVHP QVRKIGVFSC GPPGMTKNVE KACQLINRQD RTHFSHHYEN F //